ArticleNeuro-oncology2023

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

John H Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.